Magnetic Surgical System
Innovative technology that makes surgery less invasive using magnetic positioning
Device · On PremiseCompany source
Company profile
About Levita Magnetics
Levita Magnetics is a Silicon Valley-based medical device company pioneering Magnetic Surgery technology to transform surgical care worldwide. Founded by minimally invasive surgeon Dr. Alberto Rodriguez-Navarro and co-founded by businessman Nicolas Luksic, the company developed the first and only Magnetic Surgery platform designed to enhance surgical outcomes while reducing invasiveness. In 2023, Levita launched the MARS (Magnetic Surgery) Platform, which builds on the clinical benefits of magnetic positioning while providing additional advantages for surgeons and hospitals. The MARS system uses Dynamic Magnetic Positioning technology for liver retraction and tissue manipulation during minimally invasive procedures, requiring fewer incisions than traditional approaches. The platform has achieved multiple FDA clearances for general surgery, bariatric procedures, hiatal hernia repair, and pediatric use. In 2025, Levita made history by powering the world's first AI-guided autonomous surgery, demonstrating how AI-driven camera guidance can enhance precision and efficiency. The company has also pioneered the integration of augmented reality headsets (Meta Quest) with surgical robotics, offering surgeons enhanced depth perception and visualization. With over 1,000 procedures performed using the MARS system, Levita serves hospitals and surgical centers globally, with commercial presence in the United States and Chile. The company's mission is to help more patients get access to better surgery through innovative magnetic and robotic surgical solutions.
Company description Levita Magnetics official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Levita Magnetics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- bariatric surgery
- general surgery procedures requiring liver retraction
- hiatal hernia repair
- pediatric surgery
Who it serves
- Health Systems
- Hospitals
- Surgical Centers
Deployment & integration
On Premise deployment with recorded integration context.
Geographic context
MarketsChile · United States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance for pediatric use (Nov 2025), 1,000th surgery milestone (July 2025), world's first AI-guided autonomous surgery (Sept 2025), FDA expanded indication for bariatric and hiatal hernia repair (June 2025), first AR headset-enhanced surgery with Meta Quest 3 (March 2024), first international deployment in Chile (Dec 2023), first commercial deployment in private institution (April 2024), dual-system robotic surgery combining MARS and Da Vinci Single Port (Dec 2024)
Partnerships
Recorded partners
- Cleveland Clinic Children's
- Clínica Las Condes (Chile)
- Da Vinci Surgical Systems (dual-system robotic procedures)
- Meta (Quest 3 AR integration)
- Stanford University Hospital
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
MARS Platform
First-of-its-kind magnetic surgical platform harnessing the power of magnets and machines
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
A Study at Multiple Centers to Evaluate the Safety and Practicality of the Levita Magnetic Surgical System for Use in Laparoscopic Upper Gastrointestinal Surgeries.NCT07293611 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Fewer incisions required
Compared to traditional minimally invasive surgery
Enhanced precision and efficiency
Through AI-driven camera guidance
Improved surgical outcomes
Using Dynamic Magnetic Positioning technology
Cleveland Clinic Children's
First U.S. pediatric use of magnetic-assisted surgical technology following FDA clearance
Milestone procedure marking expansion of indication to pediatric patients
Clínica Las Condes
World's first AI-guided autonomous surgery using MARS Platform with AI-driven camera guidance
Enhanced precision, efficiency, and patient outcomes in high-volume surgery
Stanford University Hospital
Landmark 1,000th procedure using MARS System for minimally invasive surgery
1,000 surgeries milestone achieved demonstrating clinical adoption and scalability
Dallas Hospital (Texas)
Revolutionary robotic surgery combining MARS Platform with Da Vinci Single Port Robotic System for prostate procedure
Unprecedented precision and new standard for minimally invasive care with dual-system integration
Undisclosed Hospital
World's first robotic surgery using Meta Quest 3 AR headset and 3D visualization with MARS system
Unparalleled depth perception enabling faster and more precise procedures
North Texas Hospital
New bariatric surgery technique using MARS for weight loss surgery
Patient halfway towards weight loss goal using magnetic surgery approach
Private Institution (Undisclosed)
First deployment of MARS Surgical System in a private institution
Expansion of global accessibility to advanced, minimally invasive surgical technology
Chilean Hospital (International)
First international deployment of MARS Surgical System outside the US
International expansion achieved one month after first commercial US use
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Levita Magnetics
Recent articles published on Levita Magnetics's official website.
Levita® Magnetics Achieves First Deployment of MARS™ Surgical System in a Private Institution
Read on Levita MagneticsLevita® Magnetics Announces First International Deployment of MARS™ Surgical System
Read on Levita MagneticsLevita Magnetics Powers World’s First AI-Guided Autonomous Surgery with MARS Platform
Read on Levita MagneticsLevita® Magnetics Leads the Future of Surgery with Augmented Reality (AR) Headset-Enhanced Abdominal Surgery
Read on Levita MagneticsFDA Expands Indication for Levita Magnetics’ Magnetic Surgical System with MARS® for Minimally Invasive Bariatric and Hiatal Hernia Repair
Read on Levita Magnetics07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.